Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 05, 2022 12:52 ET | Source: BioPorto A/S

BioPorto adds Mr. Nis Kruse as EVP of Strategic Partnerships and GM of EMEA & APAC

COPENHAGEN, Denmark and BOSTON, Dec. 05, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR) today announced that Mr. Nis Kruse joined the Company as EVP of Strategic...
November 09, 2022 02:05 ET | Source: BioPorto A/S

BioPorto Announces Interim Results for the First Nine Months of 2022

Announcement no. 15 COPENHAGEN, Denmark and BOSTON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced interim financial results for the first nine months of...
November 03, 2022 12:05 ET | Source: BioPorto A/S

BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call

COPENHAGEN, Denmark and BOSTON, Nov. 03, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of kidney injury,...
September 08, 2022 08:00 ET | Source: BioPorto A/S

BioPorto to Participate in H.C. Wainwright’s 24th Annual Global Investment Conference

COPENHAGEN, Denmark and BOSTON, Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced plans to participate in the H.C. Wainwright 24th Annual Global Investment...
August 17, 2022 02:20 ET | Source: BioPorto A/S

BioPorto Announces Interim Results for the First Six Months of 2022

COPENHAGEN, Denmark and BOSTON, Aug. 17, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced interim financial results for the first six months of 2022 and business...
August 08, 2022 11:05 ET | Source: BioPorto A/S

BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call

COPENHAGEN, Denmark and BOSTON, Aug. 08, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of kidney injury,...
June 28, 2022 15:02 ET | Source: BioPorto A/S

BioPorto Achieves Targeted Enrollment in Clinical Study Supporting FDA De Novo Submission for The NGAL Test in the U.S.

COPENHAGEN, Denmark and BOSTON, June 28, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced its achievement of targeted subject enrollment for the third part of a 3-part...
June 21, 2022 11:00 ET | Source: BioPorto A/S

Moderated Webcast with BioPorto’s Management

COPENHAGEN, Denmark and BOSTON, June 21, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (CPH:BIOPOR) (BioPorto) today provided details of a previously announced session with members of its management team. ...
June 20, 2022 02:15 ET | Source: BioPorto A/S

BioPorto Appoints World Leading Expert and Pioneer on the Clinical Utility of the NGAL Biomarker, Dr. Prasad Devarajan, MD FAAP FASN, as New Senior Medical Director

COPENHAGEN, Denmark and BOSTON, June 20, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (CPH:BIOPOR) (BioPorto) today announced the appointment of Dr. Prasad Devarajan, MD FAAP FASN, as Senior Medical...
April 15, 2019 09:00 ET | Source: BioPorto A/S

BioPorto Appoints New President of BioPorto Diagnostics, Inc.

Company Plans to Bring Novel Kidney Diagnostic to US Market Hellerup, Denmark, April 15, 2019 (GLOBE NEWSWIRE) -- Today, BioPorto A/S CPH: BIOPOR (“BioPorto”) announces the appointment of Amy...